Through a decline in use of Hormone Therapies

Since the summer of 2002 American women have clearly taken fewer hormone replacement therapies. And some months later the rate of breast cancer patients began to sink in a conspicuous manner. A statistical evaluation drawn up by a team [working] with Peter Ravdin at the University of Texas emphasized this connection.

Between 1990 and 1998 the rate of breast cancer cases had regularly increased about 1.7 percent per year. The following years it regularly decreased about 1 percent per year. Then however the curve suddenly takes a sharp kink. In 2003 12 percent fewer American women fell ill with breast cancer than in the previous year.

The researchers found out that particularly women between 50 and 69 years of age were responsible for this very gratifying result. In addition, especially those cancer types whose growth is accelerated by estrogens and gestagen were affected. Both [results] suggest very much to the scientists the conclusion that a connection exists between the heavy decrease of hormone therapies since the summer of 2002 and the sinking number of breast cancer patients.

In the summer of 2002 it became publicly known that hormone therapies can increase the risk of breast cancer. This was revealed by a study of 16,000 women which was broken off prematurely due to the alarming results.

An Infomational Report for Members
From THE BRIDGE Newsletter of OIRF
Published May 15, 2007

From an information report in raum &zeit, Issue 147, May/June 2007
Machine Translation by SYSTRAN, Lernout & Hauspie, LogoMedia & Promt
Translation & redaction by: Carolyn L. Winsor, OIRF

© Copyright 2007, Raum&Zeit, Wolfratshausen, Germany

Featured News

  • Designer Pain Pills

    Stand by for Designer Pain Pills From NewsMax/October 2008 In the not-too-distant future, the pain reliever you take may be fine-tuned to your body. [...]

    October 15, 2008|Points of Interest|
  • The New MORA Therapy

    The New MORA Therapy By Erich Rasche This lecture by Erich Rasche, the RA of MORA (“MO” for Dr. Franz Morell and “RA” for Erich Rasche), was [...]

  • Book News!

    This is the story of ONDAMED, a medical device. Its father, Rolf Dieter Binder conceptionalized this technology over many years and finally birthed it [...]

    March 15, 2016|Books|
  • About the Use of Heart Rate Variability

    The HRV as a Therapy Prognosis Method Until recently the determination of the Heart Rate Variability (HRV) was an insignificant [...]

    September 15, 2009|Journal Translations|

Sign-up to receive updates sent straight to your inbox